BTK and colorectal cancer: Chen also found that CLCA4 was low expressed in patients with colorectal cancer, and believed that CLCA4 inhibited the epithelial–mesenchymal transformation of colorectal cancer through PI3K/ATK signaling pathway, thus participating in the proliferation and invasion of tumors, and may be used as a marker for diagnosis and judgment [52].